Publication | Open Access
Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1
67
Citations
30
References
2023
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1